These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 28242233

  • 1. Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes.
    Mannucci E, Monami M, Ceriello A, Rotella CM.
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):375-377. PubMed ID: 28242233
    [No Abstract] [Full Text] [Related]

  • 2. Decrease mortality in type II diabetes mellitus: glycemic and renal function control.
    Borghi C, Ventura F.
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e13-e15. PubMed ID: 29538138
    [No Abstract] [Full Text] [Related]

  • 3. Is glycemic control a quinidine-like intervention?
    Bloomgarden ZT.
    J Diabetes; 2014 Sep; 6(5):387-8. PubMed ID: 24842383
    [No Abstract] [Full Text] [Related]

  • 4. Diabetes: Time for reconciliation between cardiologists and diabetologists.
    Scheen AJ.
    Nat Rev Cardiol; 2016 Sep; 13(9):509-10. PubMed ID: 27411401
    [No Abstract] [Full Text] [Related]

  • 5. Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease.
    Shehadeh N, Raz I, Nakhleh A.
    Cardiovasc Diabetol; 2018 Aug 22; 17(1):117. PubMed ID: 30134893
    [No Abstract] [Full Text] [Related]

  • 6. Non-alcoholic fatty liver disease and type 2 diabetes: Importance of glycemic control.
    Bloomgarden Z.
    J Diabetes; 2017 Aug 22; 9(8):722-723. PubMed ID: 28513098
    [No Abstract] [Full Text] [Related]

  • 7. The shifting paradigm in the treatment of type 2 diabetes mellitus-A cardiologist's perspective.
    Fatima S, Jameel A, Ayesha F, Menzies DJ.
    Clin Cardiol; 2017 Nov 22; 40(11):970-973. PubMed ID: 28841228
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Glucose lowering strategies and cardiovascular disease in type 2 diabetes - teachings from the TOSCA.IT study.
    Vaccaro O, Masulli M, Riccardi G.
    Nutr Metab Cardiovasc Dis; 2018 Jul 22; 28(7):722-726. PubMed ID: 29804832
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diabetes. Insights from the extended follow-up of the ACCORD trial.
    Zoungas S, Woodward M.
    Nat Rev Cardiol; 2011 Jun 22; 8(6):308-10. PubMed ID: 21502962
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.